Business
Aveanna Healthcare Holdings Announces CEO Transition and Reaffirms FY 2022 Revenue and Adjusted EBITDA Guidance
ATLANTA, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings, Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing
About this update from Aveanna Healthcare Holdings Inc.
[{"type":"text","content":"ATLANTA, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings, Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced that its Chief Executive Officer and Director, Tony Strange, is retiring and will depart the company effective December 31, 2022. Jeff S. Shaner, Aveanna’s long serving Chief Operations Officer, will serve as CEO and Director, effective December 31, 2022. “Tony’s leadership was a significant part of Aveanna’s formation and growth since its inception five years ago. He leaves an enduring legacy of building one of the nation’s largest home care companies in America, during an unprecedented pandemic. Tony’s steady and stable leadership was a welcome gift during troubled waters within our industry. It has been an honor working side-by-side, with Tony, at Aveanna and the many other companies during our career together. The Board and I are confident that under Jeff’s leadership, Aveanna will continue its transition into a new era of value-based care. Jeff’s experience, passion, and innovative mindset will serve Aveanna well as we look to the future,” said Rod Windley, Chairman of Aveanna. “I am looking forward to this new leadership role as CEO and further building on the rock-solid commitment we have to clinical excellence and value creation here at Aveanna. Aveanna will continue with its mission making a positive impact in the lives of the patients and families that we serve every day,” said Mr. Shaner. Mr. Strange commented, “I am looking forward to slowing down and assisting Jeff with his transition. I have worked with Jeff for over 20 years both at Aveanna and other industry leading home-health companies. Jeff is ready to lead Aveanna into a new era of growth, innovation, and clinical value creation. I am thankful to all the Aveanna employees for the opportunity to have served as your CEO.” Aveanna also is reaffirming its most recent revised Full Year 2022 Guidance of (1) Revenue of at least $1,782 million and (2) Adjusted EBITDA of at least $128 million. Forward-Looking Statements Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements (other than statements of historical facts) in th...